Skip to content
healthcare.dev

Mucolyte

NDC 57237-359, Guaifenesin, liquid, from Rising Pharma Holdings, Inc..

Product NDC
57237-359
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57237-359 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN100 mg/5mL

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
57237-359-1257237035912118 mL in 1 BOTTLE (57237-359-12)
57237-359-1657237035916473 mL in 1 BOTTLE (57237-359-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 57237035912

    GET /v1/drugs/nadac/57237035912
  • NADAC price for package 57237035916

    GET /v1/drugs/nadac/57237035916

Use it

Look up 57237-359 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57237-359 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57237-359. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.